Epigenetic silencing of MicroRNA-503 regulates FANCA expression in non-small cell lung cancer cell

Biochemical and Biophysical Research Communications

Volumn 444, Issue 4, 2014, Pages 611-616

  Li, Ning ^a   Zhang, Fangfang ^b   Li, Suyun ^a   Zhou, Suzhen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HENAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

FANCA; Methylation; miR 503; Non small cell lung cancer cell

Indexed keywords

FANCA; METHYLATION; MIR-503; NON-SMALL CELL LUNG CANCER CELL;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CISPLATIN; DNA METHYLATION; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG; LUNG NEOPLASMS; MICRORNAS;

EID: 84894521534     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.103     Document Type: Article

References (17)

1. T. Koga, M. Takeshita, T. Yano, Y. Maehara, and K. Sueishi CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer Int. J. Cancer 128 2011 1009 1017
2. K.M. Hong, S.H. Yang, S.R. Chowdhuri, A. Player, M. Hames, J. Fukuoka, D. Meerzaman, T. Dracheva, Z. Sun, P. Yang, and J. Jen Inactivation of LLC1 gene in nonsmall cell lung cancer Int. J. Cancer 120 2007 2353 2358
3. H. Shen, T. Liu, L. Fu, S. Zhao, B. Fan, J. Cao, and X. Li Identification of microRNAs involved in dexamethasone-induced muscle atrophy Mol. Cell Biochem. 381 2013 105 113
4. J.J. Zhao, J. Lin, T. Lwin, H. Yang, J. Guo, W. Kong, S. Dessureault, L.C. Moscinski, D. Rezania, W.S. Dalton, E. Sotomayor, J. Tao, and J.Q. Cheng microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma Blood 115 2010 2630 2639
5. B. Zhou, R. Ma, W. Si, S. Li, Y. Xu, X. Tu, and Q. Wang MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth Cancer Lett. 333 2013 159 169
6. J. Zhou, and W. Wang Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell J. Surg. Oncol. 104 2011 278 283
7. F. Xiao, W. Zhang, L. Chen, F. Chen, H. Xie, C. Xing, X. Yu, S. Ding, K. Chen, H. Guo, J. Cheng, S. Zheng, and L. Zhou MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma J. Transl. Med. 11 2013 195
8. Y.Y. Xu, H.J. Wu, H.D. Ma, L.P. Xu, Y. Huo, and L.R. Yin MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1 FEBS J. 280 2013 3768 3779
9. T. Qiu, L. Zhou, T. Wang, J. Xu, J. Wang, W. Chen, X. Zhou, Z. Huang, W. Zhu, Y. Shu, and P. Liu MiR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2 Int. J. Mol. Med. 32 2013 593 598
10. J.C. Wong, N. Alon, C. McKerlie, J.R. Huang, M.S. Meyn, and M. Buchwald Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia Hum. Mol. Genet. 12 2003 2063 2076
11. M. Ferrer, J.P. de Winter, D.C. Mastenbroek, D.T. Curiel, W.R. Gerritsen, G. Giaccone, and F.A. Kruyt Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA Cancer Gene Ther. 11 2004 539 546
12. A.D. Auerbach Fanconi anemia and its diagnosis Mutat. Res. 668 2009 4 10
13. N. Li, X. Li, S. Li, S. Zhou, and Q. Zhou Cisplatin-induced downregulation of SOX1 increases drug resistance by activating autophagy in non-small cell lung cancer cell Biochem. Biophys. Res. Commun. 439 2013 187 190
14. X.H. Wang, R.Z. Qian, W. Zhang, S.F. Chen, H.M. Jin, and R.M. Hu MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats Clin. Exp. Pharmacol. Physiol. 36 2009 181 188
15. J.J. Zhao, J. Yang, J. Lin, N. Yao, Y. Zhu, J. Zheng, J. Xu, J.Q. Cheng, J.Y. Lin, and X. Ma Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis Childs Nerv. Syst. 25 2009 13 20
16. J. Song, M. Teplova, S. Ishibe-Murakami, and D.J. Patel Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation Science 335 2012 709 712
17. M.V. Mishra, K.S. Bisht, L. Sun, K. Muldoon-Jacobs, R. Awwad, A. Kaushal, P. Nguyen, L. Huang, J.D. Pennington, S. Markovina, C.M. Bradbury, and D. Gius DNMT1 as a molecular target in a multimodality-resistant phenotype in tumor cells Mol. Cancer Res. 6 2008 243 249